Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 216990
Company: TORRENT

Products on ANDA 216990

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TIOPRONIN	TIOPRONIN	100MG	TABLET, DELAYED RELEASE;ORAL	Prescription	AB	No	No
TIOPRONIN	TIOPRONIN	300MG	TABLET, DELAYED RELEASE;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 216990

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/30/2024	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/216990Orig1s000ltr.pdf

Therapeutic Equivalents for ANDA 216990

TIOPRONIN

TABLET, DELAYED RELEASE;ORAL; 100MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
THIOLA EC	TIOPRONIN	100MG	TABLET, DELAYED RELEASE;ORAL	Prescription	Yes	AB	211843	MISSION PHARMACAL
TIOPRONIN	TIOPRONIN	100MG	TABLET, DELAYED RELEASE;ORAL	Prescription	No	AB	216990	TORRENT

TABLET, DELAYED RELEASE;ORAL; 300MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
THIOLA EC	TIOPRONIN	300MG	TABLET, DELAYED RELEASE;ORAL	Prescription	Yes	AB	211843	MISSION PHARMACAL
TIOPRONIN	TIOPRONIN	300MG	TABLET, DELAYED RELEASE;ORAL	Prescription	No	AB	216278	AMNEAL
TIOPRONIN	TIOPRONIN	300MG	TABLET, DELAYED RELEASE;ORAL	Prescription	No	AB	216990	TORRENT